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Comparison of Lipid-Related Ratios for Prediction of Chronic 
Kidney Disease Stage 3 or More in Korean Adults
Dyslipidemia is implicated in increased cardiovascular risk associated with chronic kidney 
disease (CKD) and in the progression of renal damage. This study compared 4 different 
lipid-related ratios (total cholesterol [TC]/high-density lipoprotein cholesterol [HDL-C], 
triglyceride [TG]/HDL-C, calculated low-density lipoprotein cholesterol [c-LDL-C]/HDL-C, 
and non-HDL-C/HDL-C ratio) for prediction of CKD stage 3 or more to investigate the 
association between them. This cross-sectional study included 8,650 adults who 
participated in the 2007-2008 Korean National Health and Nutrition Examination Survey. 
The overall prevalence of CKD stage 3 or more was 6.4%. For TG/HDL-C, the prevalence 
with CKD stage 3 or more increased with increasing quartile group in both sexes (P value 
for trend = 0.046 in men, 0.002 in women) while other lipid-related ratios showed 
increasing prevalence only in women. In comparison with the lowest quartile of the lipid-
related ratios, only the fourth quartile of TG/HDL-C was associated with the prevalence of 
CKD stage 3 or more in both sexes after adjustment for multiple covariates (odds ratio [OR] 
for TG/HDL-C-Q4, 1.82; 95% CI [confidence interval], 1.09-3.03 in men, OR 2.45; 95% 
CI, 1.52-3.95 in women). In conclusion, TG/HDL-C is the only lipid-related ratio that is 
independently associated with CKD stage 3 or more in both sexes of Koreans.
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INTRODUCTION
The number of people affected by chronic kidney disease (CKD) 
or who require renal replacement therapy is steadily increasing 
(1). Cardiovascular disease (CVD) accounts by far for the larg-
est proportion of fatalities in people with CKD (2). Dyslipidemia 
including increased total cholesterol (TC), triglycerides (TG), 
and low-density lipoprotein cholesterol (LDL-C) concentrations 
and decreased high-density lipoprotein cholesterol (HDL-C) is 
one of the risk factors implicated in increased cardiovascular 
risk associated with CKD and also in the progression of renal 
damage (3, 4). Therefore, early identification and proper man-
agement not only of CKD but also of dyslipidemia can prevent 
the progression of end stage renal disease (ESRD) and the de-
velopment of associated morbidities including CVD. 
 Clinical trials in the general population and in established 
CVD patients have found that management of dyslipidemia is 
consistently and independently associated with the reduction 
of all-cause mortality and cardiovascular mortality (5, 6). Sever-
al studies have compared different lipid-related ratios for pre-
diction of atherosclerotic CVD (7-9). However, data on the as-
sociation of each lipid-related ratio with CKD and the data on 
the use of lipid-related ratios for prediction of CKD is still lack-
ing, particularly on methods for comparison. A recent study re-
ported that TG/HDL-C is positively associated with CKD preva-
lence, but other lipid-related ratios were not evaluated or com-
pared in the study (10).
 The National Cholesterol Education Program has proposed 
the widespread use of non–high-density lipoprotein cholesterol 
(nHDL-C) as a secondary target of therapy, after the primary 
target of LDL-C has been attained (11). nHDL-C is the differ-
ence between TC and HDL-C and accounts for LDL-C, very 
low-density cholesterol (VLDL) particles, and its remnants that 
reflects the increased risk of coronary heart disease.
 Because current lipid-lowering strategies do not control com-
plications of hyperlipidemia as well as they should (12), and be-
cause the indices focus on somewhat different aspects of a com-
plex lipid profile, it is important to understand the aspects of each 
lipid index which controls dyslipidemia-associated complications.
 Therefore, we investigated the relationships between several 
lipid-related ratios and CKD prevalence. We also compared the 
lipid-related ratios for prediction of CKD in a nationally repre-
sentative sample of Korean adults.
 
MATERIALS AND METHODS
Study subjects
This study was based on data obtained from the 2007-2008 Ko-
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rean National Health and Nutrition Examination Survey (KNH- 
ANES), a cross-sectional and nationally representative survey 
that was conducted by the Korean Centers for Disease Control 
and Prevention, from July, 2007 to December, 2008. Non-insti-
tutionalized civilians in Korea, at least one year of age, were the 
target population of the survey. Sampling units were households 
that were selected through a stratified, multistage, probability-
sampling design that was based on geographic area, gender, 
and age from a database of household registries. Three-hun-
dred sampling frames, consisting of 6,900 households from the 
primary sampling units, were randomly sampled. Of these, 5,424 
households (78.6%) were included in the study. To enable the 
results from this study to represent the entire population of Ko-
rea, weights indicating the probability of being sampled were 
assigned to each participant. Participants completed three parts 
of a questionnaire, composed of a Health Interview Survey, 
Health Examination Survey, and Nutrition Survey. 
 The 2007-2008 KNHANES had 18,983 initial target samples. 
The Health Examination Survey and the Health Interview Sur-
vey were completed by 13,554 (71.4%) of total samples. We ex-
cluded individuals younger than 19 yr of age, who were taking 
any lipid-lowering medications, with known histories of any 
malignancy, without laboratory data such as creatinine and lip-
ids, or who had not fasted for at least 12 hr prior to blood sam-
pling. A total of 8,650 individuals (3,644 men and 5,006 women) 
were included in the final analysis.
Data collection
At the time the 2007-2008 KNHANES was conducted, target 
samples were informed that they had been randomly selected 
as a household to voluntarily participate in a survey conducted 
by the Korean Centers for Disease Control and Prevention. In 
accordance with the National Health Enhancement Act, sup-
ported by the National Statistics Law of Korea, all target samples 
were given the right to refuse to participate. 
 Trained medical staff performed physical examinations ac-
cording to standardized procedures. Body weight and height 
were measured in light indoor clothing without shoes to the 
nearest 0.1 kg and 0.1 cm, respectively. Waist circumference was 
measured at the narrowest point between the lower border of 
the rib cage and the iliac crest. Body mass index (BMI) was cal-
culated as the ratio of weight/height2 (kg/m2). Systolic blood 
pressure (SBP) and diastolic blood pressure (DBP) were mea-
sured using the right arm with a standard mercury sphygmoma-
nometer (Baumanometer, Copiague, NY, USA). The average of 
two systolic and diastolic blood pressure readings, recorded at 
an interval of 5 min, was used for analysis. After 12 hr of over-
night fasting, blood samples were obtained from the antecubi-
tal veins of the study subjects. Fasting plasma glucose, TC, TG, 
HDL-C, and creatinine levels were measured using an ADIVIA 
1650 chemistry analyzer (Siemens, Washington, DC, USA).
Definitions of regular drinker, CKD and lipid-related ratios
We defined a regular drinker as a participant who had more 
than one drinking episode per a month. We defined CKD stage 
3 or more as an estimated glomerular filtration rate (eGFR) be-
low 60 mL/min/1.73 m2 (13). The eGFR was calculated using 
the abbreviated equation from the Modification of Diet in Re-
nal Disease (MDRD) study: 186.3 × (serum creatinine-1.154) ×  
(age-0.203) × 0.742 (if female) (14). LDL-cholesterol was indirect-
ly calculated using Friedewald’s formula: TC – HDL-C – (TG/5) 
(15). nHDL-C was calculated as HDL-C subtracted from TC. 
Each of four lipid-related ratios as TC (mg/dL), TG (mg/dL), cal-
culated LDL-C (cLDL-C) (mg/dL), and nHDL-C (mg/dL) were 
divided by HDL-C (mg/dL). 
 We classified each lipid-related ratio into quartile groups in 
each sex. These groups were categorized as follows: TC/HDL-C 
Q1, < 3.40; Q2, 3.40-4.18; Q3, 4.19-5.00; Q4, ≥ 5.10 in men; Q1, 
< 3.05; Q2, 3.05-3.75; Q3, 3.76-4.64; Q4, ≥ 4.65 in women; TG/
HDL-C Q1, < 1.74; Q2, 1.74-2.82; Q3, 2.83-4.65; Q4, ≥ 4.66 in 
men; Q1, < 1.19; Q2, 1.19-1.94; Q3, 1.95-3.24; Q4, ≥ 3.25 in wom-
en; cLDL-C/HDL-C Q1, < 1.87; Q2, 1.87-2.46; Q3, 2.47-3.21; Q4, 
≥ 3.22 in men; Q1, < 1.73; Q2, 1.73-2.28; Q3, 2.29-2.96; Q4, ≥ 2.97 
in women; nHDL-C/HDL-C Q1, < 2.40; Q2, 2.40-3.18; Q3, 3.19-
4.09; Q4, ≥ 4.10 in men; Q1, < 2.05; Q2, 2.05-2.75; Q3, 2.76-3.64; 
Q4, ≥ 3.65 in women.
Statistical analysis
With the exceptions of TG and lipid-related ratios, the charac-
teristics of the study sample were summarized using the inde-
pendent two-sample t-test for continuous variables and the chi-
square test for categorical variables. To compare the median 
values of TG and lipid-related ratios, we used the Mann-Whit-
ney U test due to accommodate skewedness. We investigated 
the relationship between eGFR and other continuous variable, 
using Pearson’s correlation analysis. Odds ratios (ORs) and 95% 
confidence intervals (95% CIs) for CKD stage 3 or more were 
calculated using logistic regression analysis after adjustment for 
other covariates across quartiles of lipid-related ratios. P  value 
for trend was determined by linear regression analysis. Analysis 
was conducted using SAS statistical software, version 9.1 (SAS 
Institute Inc., Cary, NC, USA). All statistical tests were two-sided, 
and statistical significance was determined at P  value < 0.05.
Ethics statement
Written informed consent to participate in the study was ob-
tained from participants and their parents (if applicable). The 
participants also provided written informed consents for the 
use of blood samples in further analyses, to the Korea Centers 
for Disease Control and Prevention. This study was approved 
by the institutional review board of Gangnam Severance Hospi-
tal, Yonsei University, Seoul, Korea (Approval number: 3-2011-
0161).
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RESULTS
Table 1 shows characteristics of the 8,650 adult subjects (3,644 
men and 5,006 women). The mean age of men and women 
were 48.5 and 48.6 yr, respectively. The mean or median values 
of BMI, waist circumference, SBP, DBP, fasting plasma glucose, 
TC, HDL-C, TG, cLDL-C, nHDL-C, TC/HDL-C, TG/HDL-C, 
cLDL-C/HDL-C, nHDL-C/HDL-C, and creatinine were higher 
in men than in women, while serum HDL-C levels were higher 
in women than in men. The mean value of eGFR did not differ 
between men and women. The percentages of subjects who 
were current smokers, current alcohol drinkers, or engaged in 
regular exercise were higher in men, while the percentage of 
subjects with CKD stage 3 or more was higher in women (4.7% 
in men versus 7.7% in women).
 Table 2 shows Pearson’s correlations among eGFR, lipid-re-
lated ratios, and other risk factors in each sex. Age, SBP, fasting 
plasma glucose, waist circumference, BMI, TC, logarithm-trans-
formed (log) TG, cLDL-C, nHDL-C, log TC/HDL-C, log TG/HDL-
C, log cLDL-C/HDL-C and log nHDL-C/HDL-C were negative-
ly correlated with eGFR, while HDL-C was positively associated 
with eGFR in both sexes. All values were statistically significant 
(P  value < 0.05). 
 Fig. 1 shows the prevalence of CKD stage 3 or more accord-
ing to lipid-related ratios quartile. The overall prevalence of CKD 
stage 3 or more was 6.4%. For TG/HDL-C, the percentage of sub-
jects with CKD stage 3 or more increased with higher quartile 
group in both men and women (P  value for trend = 0.046 in 
men, 0.002 in women). For TC/HDL-C, cLDL-C/HDL-C, nHDL- 
C/HDL-C, the percentage of subjects with CKD stage 3 or more 
increased with higher quartile group only in women. 
 Fig. 2 shows the ORs for CKD stage 3 or more according to 
lipid-related ratios quartile after adjustment for age, SBP, fasting 
plasma glucose, waist circumference, BMI, smoking status, al-
cohol-drinking status, and exercise status for each sex. In com-
paring participants who were categorized in the first quartiles 
of each lipid-related ratio, only the fourth quartile of TG/HDL-
C was associated with CKD stage 3 or more for men. The ORs 
(95% CIs) for CKD stage 3 or more of participants who were cat-
egorized in the TG/HDL-C-Q4 was 1.82 (1.09-3.03) in men. For 
women, the fourth quartile of TC/HDL-C, the third and fourth 
quartile of TG/HDL-C, and the fourth quartile of nHDL-C/
HDL-C were associated with CKD stage 3 or more. ORs (95% 
CIs) were 1.75 (1.13-2.73) in TC/HDL-C-Q4, 2.34 (1.44-3.79) 
in TG/HDL-C-Q3, 2.45 (1.52-3.95) in TG/HDL-C-Q4 and 1.75 
(1.13-2.73) in nHDL-C/HDL-C-Q4. The ORs for CKD stage 3 or 
more increased in higher quartile group for all lipid-related ra-
tios in women. All P  values for trends of each lipid-related ratio 
Table 1. Basic characteristics of the study subjects (n = 8,650)
Parameters
Men  
(n = 3,644)
Women  
(n = 5,006)
P  value
Age (yr)   48.5 ± 16.1   48.6 ± 16.8 0.799*
BMI 23.9 ± 3.1 23.3 ± 3.1 < 0.001*
WC (cm) 84.6 ± 8.8   79.6 ± 10.0 < 0.001*
SBP (mmHg) 119.0 ± 15.7 114.0 ± 18.1 < 0.001*
DBP (mmHg)   77.9 ± 10.4   72.8 ± 10.4 < 0.001*
FPG (mg/dL)   99.0 ± 24.0   95.7 ± 23.2 < 0.001*
TC (mg/dL) 186.8 ± 35.0 189.2 ± 36.7 0.002*
HDL-C (mg/dL)   45.6 ± 11.6   50.7 ± 13.0 < 0.001*
TG (mg/dL) 122.0  
(84.0, 185.0)
96.0  
(66.75, 142.0)
< 0.001†
cLDL-C (mg/dL) 110.6 ± 40.0 115.0 ± 32.7 < 0.001*
nHDL-C (mg/dL) 141.2 ± 35.5 138.5 ± 37.5 0.001*
TC/HDL-C 4.19 (3.40, 5.10) 3.76 (3.05, 4.65) < 0.001†
TG/HDL-C 2.83 (1.74, 4.66) 1.95 (1.19, 3.25) < 0.001†
cLDL-C/HDL-C 2.47 (1.87, 3.22) 2.29 (1.73, 2.97) < 0.001†
nHDL-C/HDL-C 3.19 (2.40, 4.10) 2.76 (2.05, 3.65) < 0.001†
Creatinine (mg/dL)   1.06 ± 0.27   0.83 ± 0.21 < 0.001*
eGFR (mL/min/1.73 m2)   82.5 ± 15.1   82.4 ± 17.9 0.665*
Smoking status (%)
   Never smoker
   Former smoker
   Current smoker
 
18.1
37.7
44.3
 
88.2
  6.1
  5.8
< 0.001‡
Drinking status (%)
   Non-drinker
   Regular drinker
26.9
73.1
61.0
39.0
< 0.001‡
Regular exercise (%)
   None
   1-2 times/week
   3-4 time/week
 
54.3
18.4
27.2
 
63.1
13.1
23.8
< 0.001‡
CKD stage 3 or 
   more prevalence (%)
  4.7   7.7 < 0.001‡
*P value as determined by independent two-sample t-test; †P value as determined by 
Mann-Whitney U test; ‡P value as determined by chi-squared test. BMI, body mass 
index; WC, waist circumference; SBP, systolic blood pressure; DBP, diastolic blood 
pressure; FPG, fasting plasma glucose; TC, total cholesterol; HDL-C, high density lipo-
protein-cholesterol; TG, triglyceride; cLDL-C, calculated low density lipoprotein-cho-
lesterol; nHDL-C, non-high density lipoprotein-cholesterol; CKD, chronic kidney dis-
ease.
Table 2. Pearson’s correlation among eGFR and other continuous variables
Variables
Men Women
Coefficient P Coefficient P
Age -0.368 < 0.001 -0.463 < 0.001
SBP -0.137 < 0.001 -0.275 < 0.001
FPG -0.056 < 0.001 -0.138 < 0.001
WC -0.145 < 0.001 -0.173 < 0.001
BMI -0.087 < 0.001 -0.136 < 0.001
TC -0.08 < 0.001 -0.176 < 0.001
HDL-C 0.19 < 0.001 0.224 < 0.001
log TG -0.073 < 0.001 -0.17 < 0.001
cLDL-C -0.137 < 0.001 -0.224 < 0.001
nHDL-C -0.141 < 0.001 -0.249 < 0.001
log (TC/HDL-C) -0.228 < 0.001 -0.312 < 0.001
log (TG/HDL-C) -0.131 < 0.001 -0.215 < 0.001
log (cLDL-C/HDL-C) -0.228 < 0.001 -0.307 < 0.001
log (nHDL-C/HDL-C) -0.23 < 0.001 -0.309 < 0.001
P  value as determined by Pearson’s correlation analysis. log, logarithm-transformed; 
BMI, body mass index; WC, waist circumference; SBP, systolic blood pressure; FPG, 
fasting plasma glucose; TC, total cholesterol; HDL-C, high density lipoprotein-choles-
terol; TG, triglyceride; cLDL-C, calculated low density lipoprotein-cholesterol; nHDL-C, 
non-high density lipoprotein-cholesterol;
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Fig. 1. Prevalence of chronic kidney disease stage 3 or more according to lipid-related ratios quartile for each sex. For TG/HDL-C, the percentage of subjects with CKD stage 3 
or more increased with increasing quartile group in both men and women. For TC/HDL-C, cLDL-C/HDL-C, nHDL-C/HDL-C, the percentage of subjects with CKD stage 3 or more 
increased with increasing quartile group only in women. 
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Fig. 2. Odds ratios for CKD stage 3 or more according to lipid-related ratios quartiles after adjustment for age, SBP, fasting plasma glucose, waist circumference, BMI, smoking 
status, alcohol-drinking status, and exercise status for each sex. In comparison with participants who were categorized in the first quartiles of each lipid-related ratio, only the 
fourth quartile of TG/HDL-C was associated with CKD stage 3 or more for men. For women, the fourth quartile of TC/HDL-C, the third and fourth quartile of TG/HDL-C, and the 
fourth quartile of nHDL-C/HDL-C were associated with CKD stage 3 or more. The ORs for CKD stage 3 or more increased with increasing quartile group for all lipid-related ratios 
in women. 
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were < 0.05.
DISCUSSION
The major finding of this study was that evaluated lipid-related 
ratios were correlated with the prevalence of CKD stage 3 or 
more. This correlation was more significant in women than in 
men. TG/HDL-C was the only lipid-related ratio that was asso-
ciated with the prevalence of CKD stage 3 or more in both men 
and women.
 After adjusting for age, SBP, fasting plasma glucose, waist cir-
cumfernece, BMI, smoking status, drinking status and exercise 
status, TG/HDL-C was shown to have the strongest association 
among the lipid-related ratios. For men, TG/HDL-C was the only 
lipid index that was associated with CKD stage 3 or more though 
the increasing trend between OR and quartile of TG/HDL-C had 
borderline significance (with a P  value of 0.060). For women, 
while all of the lipid-related ratios have a significant increasing 
trend between quartile and OR, TG/HDL-C increased the most 
with Q3 and Q4 as compared with other lipid-related ratios. This 
supports not only existing study results that TG/HDL-C associ-
ates with CKD independently (10), but also the hypothesis that 
TG/HDL-C is a better index than other lipid-related ratios.
 TG/HDL-C has been identified as an indicator of insulin re-
sistance and atherosclerosis in addition to their comorbidities 
(16). Increased TG/HDL-C may be associated with glomerulo-
sclerosis, which is related to the development of CKD. Although 
the mechanism of CKD development is not clearly understood, 
CKD shares many risk factors with CVD. In addition to the tra-
ditional risk factors of CKD including hypertension, diabetes 
mellitus and aging, chronic inflammation, oxidative stress and 
obesity are also indicators of renal dysfunction development 
(17, 18). On a cellular level, it has been shown that when mesan-
gial cells are stimulated by being exposed to lipids, they secrete 
proinflammatory cytokines such as interleukin-6, tumor necro-
sis factor-α, and transforming growth factor-β (19). Glomerular 
mesangial cells and vascular smooth muscle cells have molec-
ular similarities, pointing to a common underlying pathophysi-
ology in the development of atherosclerosis and glomeruloscle-
rosis (20, 21). 
 Insulin resistance mediates diabetes, obesity, hypertension, 
lipid abnormalities and atherosclerosis, which are all risk fac-
tors of CKD and CVD (22, 23). Insulin resistance is also a signifi-
cant risk factor for the progression of renal dysfunction in non-
diabetic subjects (24). TG/HDL-C is an indicator of insulin re-
sistance and cardiovascular mortality (16). Increased levels of 
small and dense LDL-C particles, which are highly atherogenic, 
are associated with elevated TG/HDL-C (25, 26). These findings 
suggest that increased TG/HDL-C may result in glomeruloscle-
rosis and CKD. The stronger relationship between CKD stage 3 
or more and TG/HDL-C, compared with other lipid-related ra-
tios in this study, may be due to correlations with insulin resis-
tance.
 Regarding the relevance of associations of lipid-related ratios 
and CKD prevalence, this study showed stronger significance 
in women. This may be due to the MDRD equation which was 
used to calculate the eGFR. Since the MDRD equation multi-
plies 0.7 in women, the prevalence of CKD stage 3 or more in 
men may be underestimated. As seen in this study, the preva-
lence of CKD stage 3 or more was 4.7% in women, which was 
significantly lower than 7.7% in men. We expect to see stronger 
significance if the GFR estimating equation was developed for 
the Korean population.
 To our knowledge, this is the first study to compare lipid- 
related ratios for prediction of CKD stage 3 or more. Although 
Schaeffner et al. (27). showed that elevated TC, nHDL-C, TC/
HDL-C, and reduced HDL-C were associated with renal dys-
function in men and Kang et al. (10) showed that increased TG/
HDL-C has a correlation with CKD prevalence, they did not 
compare the lipid-related ratios in each sex for CKD prediction. 
Furthermore, our study of 2007-2008 KNHANES participants, a 
national representative sample of Korean adults, and the num-
ber of participants are larger than previous studies.
 Some limitations should be considered when interpreting 
the findings of this study. First, the cross-sectional study design 
makes determining a causal relationship between lipid-related 
ratios and increased risk of CKD stage 3 or more difficult. Al-
though increased TG/HDL-C induced by renal dysfunction can 
aggravate the progression of CKD through lipid nephrotoxicity 
(28), CKD itself can affect the metabolism of lipoprotein and 
change TG/HDL-C. Second, we defined CKD stage 3 or more 
as an eGFR less than 60 mL/min/1.73 m2 using the MDRD for-
mula and there could be a difference with the accurate CKD 
stage 3 or more patient. The eGFR may not accurately estimate 
the actual GFR. Since the creatinine level was measured only 
once in KNHANES, the eGFR could reflect not a chronic status 
but a temporary decrease of renal function. Furthermore, since 
the MDRD formula was developed using study samples of pri-
marily European descents, the formula may not apply as pre-
cisely to Koreans. Third, we did not include individuals with pro-
teinuria, which may constitute a phenotype of CKD. However, 
because urine samples collected in KNHANES were not the first 
voided morning urine, it is difficult to obtain a quantitative mea-
surement and to control for selection bias. Finally, Friedewald’s 
formula was used to calculate LDL-C, hence serum LDL-C level 
was not measured in KNHANES. This inaccuracy of LDL-C/
HDL-C could have affected the results, particularly for patients 
with high TG levels.
 In conclusion, it is suggested that TG/HDL-C is the only lip-
id-related ratio significantly associated with CKD for both men 
and women in a sample of Korean adults. Other lipid-related 
ratios demonstrate less significance. Prospective studies inves-
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tigating the causal relationship between lipid-related ratios and 
risk of CKD are needed to evaluate the value of lipid-related ra-
tio control for CKD prevention.
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